Braveheart (AIM: BRH), the fund management and strategic investment group, is pleased to announce that it has conditionally acquired 22,145 shares in Phasefocus Holdings Limited (“Phasefocus”) from Synergy Investments Limited
N4 Pharma Plc (AIM:N4P) Warrants cash to be used to accelerate vaccine plans
13 Dec 2017: The Company announces that it has received an exercise notice for the exercise of 2,071,429 warrants over ordinary shares of 0.4p each at an exercise price of